MTAU9937A Uses, Dosage, Side Effects and more

MTAU9937A is under investigation in clinical trial NCT03289143 (A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease).

Trade Name MTAU9937A
Generic Semorinemab
Semorinemab Other Names MTAU9937A, Semorinemab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share